drugset / Trial / NCT00440115

Disease Management for Smoking Cessation

NCT00440115

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the number of quit attempts, and smokers motivation at 24 months between participants receiving high and low intensity disease management and those receiving usual care.

Timeline

Start
2009-06
Primary completion
2010-12
Completion
2010-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Bupropion Small molecule

Indications

No indication recorded.